Almac Discovery is an independent drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets which are then licenced to pharmaceutical partners for further development. Key research themes include protein homeostasis (specifically focussed on deubiquitinase enzymes) and next-generation protein drug conjugates.
The Company is unique in the field of small biotechs in having access to both small molecule and protein/peptide-based approaches and is focussed on two key platform areas (Deubiquitinases and protein-drug conjugates) which exploit these modalities. The team is located in state-of-the-art facilities on the Queen’s University Belfast life sciences campus, close to two major hospitals and the Northern Ireland Cancer Centre, and has laboratories in Edinburgh (Protein Therapeutics) and offices in Alderley Park, Cheshire (Bioinformatics).